MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
11.47
-0.31 (-2.63%)
Nov 2, 2026, 4:00 PM EST - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $976.17 million as of November 2, 2026. It is the 9,890th most valuable company in the world and the 2,236th biggest in the United States. Its market cap has increased by 52.20% in one year.
Market Cap
976.17M
Enterprise Value
540.68M
1-Year Change
52.20%
Global Rank
Country Rank
#2,236 United States
Category
ChartMarket Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $976.17M, an increase of 27,030.41%. That is a compound annual growth rate of 227.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 976.17M | 3.77% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 1.08B |
| Janux Therapeutics | 1.07B |
| Inhibrx Biosciences | 1.06B |
| Seaport Therapeutics | 1.05B |
| City Therapeutics | 1.03B |
| Immatics | 984.17M |
| Cullinan Therapeutics | 967.25M |
| Rigel Pharmaceuticals | 958.46M |